New Pet Tracers for Cerebral Dopamine: Should 6-[18F]Fluoro-L-Dopa be Replaced?

  • Günter Firnau
  • Raman Chirakal
  • Lindi Wahl
  • Jia Juen Chen
  • Dilip Murthy
  • Claude Nahmias
  • E. Stephen Garnett


Information about the metabolic functioning of the neurotransmitter dopamine in the central nervous system is clinically important for the biochemical assessment of disorders of locomotion and mood. These clinical conditions may result in abnormalities of -rate of synthesis of dopamine
  • activity of enzymes

  • density of dopaminergic neurons

  • density of dopamine receptors and

  • neurochemical anatomy of dopamine.


Positron Emission Tomography Multiple System Atrophy Occipital Cortex Dopa Decarboxylase Effective Dose Equivalent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barrio, J.R., Huang, S.C., Melega, W.P., Yu, D.C., Hoffman, J.M., Schneider, J.S., Satyamurthy, N., Mazziotta, J.C., and Phelps, M.E., 1990, 6-[18F]Fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures, J. Neurosci. Res. 27:487.PubMedCrossRefGoogle Scholar
  2. Bhatt, M.H., Snow, B.J., Martin, W.R.W. et al., 1991, Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow, Ann. Neurol. 39:673.CrossRefGoogle Scholar
  3. Blaschko, H., Holton, P., and Sloane, Stanley G.H., 1949, Enzymatic formation of pressor amines, J. Physiol. 180:427.Google Scholar
  4. Brooks, D.J., Salmon, E.P., Mathias, C.J. et al., 1990, The relationship between locomotor disability, autonomic dysfunction, and the integrity of the dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and parkinson’s disease, studied with PET, Brain. 113:1539.PubMedCrossRefGoogle Scholar
  5. Chirakal, R., Firnau, G., Garnett, E.S., Wahl, L.M., and Nahmias, C., 1993, 6-[18F]Fluoro-L-m-tyrosine to study the dopaminergic pathway in man, Metab. In press.Google Scholar
  6. Chirakal, R., Schrobilgen, G.J., Firnau, G., and Garnett, E.S., 1991, Synthesis of 18F-labelled fluoro-m-tyrosine, fluoro-m-tyramine and fluoro-3-hydroxyphenylacetic acid, Appl. Radiat. Isot. 42:113.CrossRefGoogle Scholar
  7. Doudet, D.J., McLellan, C.A., Aigner, T.G., et al., 1992, Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis andimproved evaluation of specific to non-specific fluorine-18-dopa uptake in brain, J. Nucl. Med. 33:1303.Google Scholar
  8. Doudet, D.J., McLellan, C.A., Carson, R., et al., 1991, Distribution and kinetics of 3–0-methyl-6-[18F]fluoro-L-dopa in the rhesus monkey brain, J. Cereb. Blood Flow & Metab. 11:726.CrossRefGoogle Scholar
  9. Firnau, G., Chirakal, R., Nahmias, C., and Garnett, E.S., 1991b, Do metabolites of 6-[18F]fluoro-L-dopa and of [l8F]fluoro-L-meta-tyrosine contribute to the F-18 accumulation in the human brain? J. Label. Compds & Radiopharm. 30:293.Google Scholar
  10. Firnau, G., Chirakal, R., Nahmias, C., and Garnett, E.S., 1991a, [18F]Fluoro-L-m-tyrosine is a better PET tracer than [18F]fluoro-dopa for the delineation of dopamiergic structures in the human brain, J. Label. Compds & Radiopharm. 30:266.Google Scholar
  11. Fowler, J.S., Volkow, N.D., Wolf, A.P., Dewey, S.L., Schlyer, D.J., MacGregor, R.R., Hitzemann, R., Logan, J., Bendriem, B., Gatley, S.J., and Christman, D., 1989, Mapping cocaine binding sites in human and baboon brain in vivo, Synaps. 4:371.CrossRefGoogle Scholar
  12. Fowler, J.S., MacGregor, R.R., Wolf, A.P., Arnett, C.D., Dewey, S.L., Schlyer, D., Christman, D., Logan, J., Smith, M., Sachs, H., Aquilonius, S.M., Bjurling, P., Halldin, C., Hartvig, P., Leenders, K.L., Lundquist, H., Oreland, L., Stålnacke, C.G., Långström, B., 1987, Mapping human brain monoamine oxidase A and B with 11C labelled suicide inactivators and PET, Science. 235:481.PubMedCrossRefGoogle Scholar
  13. Freed, C.R., Breeze, R.E., Rosenberg, N.L., et al., 1992, Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after trasnsplantation for parkinson’s disease, N. Eng. J. Med. 327:1549.CrossRefGoogle Scholar
  14. G arnett, E.S., Lang A.E., Chirakal, R., et al., 1987, A rostrocaudal gradient for aromatic amino acid decarboxylase in human striatum, Can. J. Neurol. Sci. 14:444.PubMedGoogle Scholar
  15. Garnett, E.S., Firnau, G., and Nahmias, C., 1983, Dopamine visualized in the basal ganglia of living man, N. Eng. J. Med. 327:1549.Google Scholar
  16. Garnett, E.S., Nahmias, C., and Firnau, G., 1984, Central dopamine pathways in hemiparkinsonism examined by positron emission tomography, Can. J. Neurol. Sci. 11:174.PubMedGoogle Scholar
  17. Gjedde, A., Reith, J., Dyve, S., Diksi C.M., Evans, A., and Kuwabara, H., 1991, Dopa decarboxylase activity of living human brain, Proceedings Natl. Acad. Science. 88:2721.CrossRefGoogle Scholar
  18. Hadjiconstaantinou, M., Wemlinger, T., Hubble, J., Silva, C.P. and Neff, N.H., 1992, Modulation of dopa decarboxylase in the striatum of a mouse model of parkinson’s disease, Soc. Neurosci. Abst. 18:664.Google Scholar
  19. Hartvig, P., Lindner, K.L., Tedroff, J., Bjurling, P., Hoernfelt, K., Långström, B., 1992, Regional brain kinetics of 6-fluoro-(β-nC)-L-dopa and (β-nC)-L-dopa following COMT inhibition. A study in vivo using positron emission tomography, J. Neural. Transm. Gen. Sect. 87:15.PubMedCrossRefGoogle Scholar
  20. Huang, S.C., Yu, D.C., Barrio, J.R., Grafton, S., Melega, W.P., Hoffman, J.M., Satyamurthy, N., Mazziotta, J.C., and Phelps, M.E., 1991, Kinetics and modelling of L-6-[18F]-fluoro-dopa in human positron emission tomography studies, J. Cereb. Blood Flow and Metab. 11:898.CrossRefGoogle Scholar
  21. Harvey, J., Firnau, G., and Garaett, E.S., 1985, Estimation of radiation dose in man due to 6-[18F]fluoro-L-dopa, J. Nucl. Med. 26:931.PubMedGoogle Scholar
  22. Itoh, M., Hatazawa, J., Ishiwata, K., et al., 1988, Error in 6–18F-dopa brain influx rate measured by positron emission tomography, CYRIS Ann. Rep. 1988:261.Google Scholar
  23. Kilbourn, M.R., DaSilva, J.N., Frey, K.A., Koeppe, R.A., and Kuhl, D.E., 1993, In vivo imaging of vesicular monoamine transporter in human brain using [11C]tetrabenazine and positron emission tomography, J. Neurochem. In press.Google Scholar
  24. Leenders, K.L., Palmer, A., Turton, D., et al., 1986, Dopa uptake and dopamine receptor binding visualized in the human brain in vivo, in: “Recent developments in parkinson’s disease, “Fahn, ed., Raven Press, New York.Google Scholar
  25. Leenders, K.L., Salmon, E.P., Tyrell, P., Perani, D., Brooks D.J., Sager, H., Jones, T., Marsden, C.D., and Frackowiak, S.J., 1990, The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with parkinson’s disease, Arch. Neurol. 47:1290.Google Scholar
  26. Lindvall, O., Brundin, P., Widner, H., et al., 1990, Grafts of fetal dopamine neurons survive and improve motor function in parkinson’s disease, Science, 247:574.PubMedCrossRefGoogle Scholar
  27. Lloyd, K.G., and Hornykiewicz, O., 1972, Occurrence and distribution of aromatic L-amino acid (L-dopa) decarboxylase in the human brain, J. Neurochem. 19:1549.PubMedCrossRefGoogle Scholar
  28. Melega, W.P., Perlmutter, M.M., Luxen, A., Nissenson, C.H.K., Grafton, S.T., Huang, S., Phelps, M.E., and Barrio, J.R., 1989, 4-[18F]fluoro-L-m-tyrosine: a L-3, 4- dihydroxyphenylalanine analog probing presynaptic dopaminergic function with positron emission tomography, J. Neurochem. 53:311.PubMedCrossRefGoogle Scholar
  29. Melega, W.P., Grafton, S.T., Huang, S.C., Satyamurthy, N., Phelps, M.E., and Barrio, J.R., 1991, L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography, J. Cereb. Blood Flow & Metab. 11:890.CrossRefGoogle Scholar
  30. Patlak, C.S., Blasberg, R.G., and Fenstermacher, J.D., 1983, Graphical evaluation of blood to brain transfer constants for multiple time uptake data, J. Cereb. Blood Flow Metab. 3:1.PubMedCrossRefGoogle Scholar
  31. Philips, S.R., Rozdilsky, B., and Boulton, A.A., 1978, Evidence for the presence of m-tyramine, p-tyramine, tryptamine and phenylethylamine in the rat brain and several areas of the human brain, Biol. Psychiat. 13:51.Google Scholar
  32. Reith, J., Dyve, S., Kuwabara, H., et al., 1990, Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat, J. Cereb. Blood Flow & Metab. 10:707.CrossRefGoogle Scholar
  33. Sawle, G.V., Bloomfield, P.M., Björklund, A., et al., 1992, Transplantation of fetal neurons in parkinson’s disease: PET 6-[18F]fluoro-L-dopa studies in tow patients with putaminal implants, Ann. Neurol. 31:166.PubMedCrossRefGoogle Scholar
  34. Schöllkopf, U., Groth, U., and Deng, C.Z., 1981, Enatioselective synthesis of (R)-amino acids using L-valine as chiral agent, Agnew Chem. Int. Ed. Engl. 20:798.CrossRefGoogle Scholar
  35. Shinotoh, H., Inoue, O., Suzuki, K., Yamasaki, T., Iyo, M., Hashimoto, K., Tomonaga, T., Itoh, T., Tateno, Y., and Ikehira, H., 1987, Kinetics of [nC]N, N-dimethylphenylethylamine in mice and humans: potential for measurement of brain MAO-B activity, J. Nucl. Med. 28:1006.PubMedGoogle Scholar
  36. Srinivasan, K., and Awapara, J., 1978, Substrate specificity and other properties of dopa decarboxylase from guinea pig kidney, Biochim. Biophys. Acta. 526:597.CrossRefGoogle Scholar
  37. Tong, J.H., Petitcler C.C., D’lorio, A., and Benoiton, N.L., 1971, Resolution of ring-substituted phenylalanines by the action of α-chymotrypsin on their ethyl esters, Can. J. Biochem. 49:877.PubMedCrossRefGoogle Scholar
  38. Weissman, A., and Koe, K.B., 1967, m-Fluoro-tyrosine convulsions and mortality: relationship to chatecholamine and citrate metabolism, J. Pharmacol. Exptl. Ther. 155:135.Google Scholar
  39. Wong, D.F., Babinan-Young P., Dannais, R.F., et al., 1993, In vivo imaging of baboon and human transporters by positron emission tomography and [11C]WIN 35, 428, Synaps. In press.Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Günter Firnau
    • 1
  • Raman Chirakal
    • 1
  • Lindi Wahl
    • 1
  • Jia Juen Chen
    • 1
  • Dilip Murthy
    • 1
  • Claude Nahmias
    • 1
  • E. Stephen Garnett
    • 1
  1. 1.Department of Radiology and Nuclear Medicine, Chedoke-McMaster HospitalsMcMaster University Health Sciences CentreHamiltonCanada

Personalised recommendations